Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Anita Joshua NEW DELHI: Communist Party of India (Marxist) Polit Bureau member Brinda Karat on Tuesday urged Union Health Minister Anbumani Ramadoss to permit the Pasteur Institute, Coonoor; the BCG Laboratory, Chennai, and the Central Research Institute, Kasauli, to resume production of vaccines to meet the shortage in DPT and …
Honey samples, collected from the Southern Marmara region of Turkey, were analysed for erythromycin residues by liquid chromatography-mass spectrometry using electrospray ionization in the positive ion mode (LC-ESI-MS). Fifty samples, comprising chestnut, pine, linden and multi-flower honeys, were collected directly from hives and analyzed. The limit of detection and quantification …
commonly used medicines like Becosule, Dexorange and Corex figure in the list of medicines that the government wanted removed from the market last year. But these medicines, classified under fixed dose combinations, or fdcs, continue to be sold. The pharma industry is reviewing the list currently. Health activists fear that …
Big pharma has big incentives, including cost savings and more powerful studies, to launch trials in developing countries. But can companies avoid the ethical potholes?
Joe C Mathew / New Delhi October 3, 2008, 0:56 IST The World Health Organization (WHO) has given five more months to the Drugs Controller General of India (DCGI) to upgrade its performance to international standards. The extension of the current deadline of October-end came after a visiting WHO team …
Business Standard / New Delhi October 1, 2008, 0:09 IST One more round has started in the battle between drug patent holders and generics players with Swiss firm Hoffman-La Roche filing a patent infringement suit against Indian generics leader Cipla for launching a copy of its anti-infection drug Valcyte. This …
Bs Reporter / Chennai September 30, 2008, 0:08 ISTOrchid Chemicals and Pharmaceuticals today said that it has entered into an arrangement with US drug maker Merck & Co for the discovery and development of novel anti-infective drugs, which have a revenue potential of over $100 million.While the deal has been …
Who will benefit from globally promoted pneumonia vaccine? the pneumonia vaccine that the Global Alliance for Vaccines and Immunization, a public-private coalition, and who are promoting in developing countries is expensive, inefficient and causes serious side-effects, contends a letter published in a public health journal. In a letter to the …
Last year, Anusha, 30, took a new weight-loss drug for seven months to combat her obesity. Although it helped her shed between 5 kg and 8 kg, she claims, there were side effects.
Bloomberg / Mumbai September 26, 2008, 0:14 IST American relief programme suspends funding for three generic medicines. AIDS drugs made by Ranbaxy Laboratories won't be purchased under an American programme to supply medicines to developing countries after the US cited the company for violations in two of its plants. The …
D G Shah Secretary General IPA* A sense of doom is not at all warranted THE recent FDA action is a warning for several other companies that are already in the US market or intend to enter it in the near future. Just as they had learnt to emulate the …
By Dr Gopal Dabade The WHO should be an honest broker between the needs of the public and vaccine manufacturers. The term vaccine was coined by Edward Jenner, during 1796, when he observed that the milk-maid did not acquire small-pox as she was having protection and further he realised that …
Mumbai: Inspite of the best efforts of the Drugs Controller General of India Surinder Singh, the Union government has instructed the closure of the BCG Vaccine Lab at Chennai. While the assets and technology of the 60-year-old unit are to be transferred to Hindustan Latex, the government is proposing to …
Daiichi Sankyo has said that there are procedural delays in completing the open offer for acquiring an additional 20% equity of Ranbaxy. The delay pertains to payments to shareholders who have subscribed to the Japanese company's open offer for acquiring an additional 20% equity of Ranbaxy. Daiichi will pay interest …
